The College of New Jersey

Apply     Visit     Give     |     Alumni     Parents     Offices     TCNJ Today     

COVID-19 Funding Opportunities

This list is updated weekly.

Federal Funding Opportunities
Agency Link Deadline
BARDA BARDA is soliciting proposals for the advanced research and development of medical countermeasures under the BARDA Broad Agency Announcement 10/31/2020
Dept. of Energy COVID-19 High Performance Computing Consortium: Invites researchers to submit COVID-19 related research proposals to the consortium, which will then be reviewed for matching with computing resources. Rolling
HHS NIA Multi-site COVID-19 Related Clinical Trial Implementation Grant on Aging-Related Topics in at-risk Older Adult Populations (R01 Clinical Trial Required) (NIH) July 1, 2020; August 3, 2020; September 1, 2020; October 1, 2020; November 2, 2020; December 1, 2020; January 4, 2021; and February 1, 2021
HHS Community Interventions to Address the Consequences of the COVID-19 Pandemic among Health Disparity and Vulnerable Populations (R01 Clinical Trial Optional) (NIH) August 28, 2020; December 1, 2020
HHS Projects that will further enable the coordination and development of testing and associated products that meet the current and future needs, and the effective transition of technology into broad use without impediments. The primary areas of focus should specifically include (1) Scaling and Networking of Technologies, and (2) Testing Demonstrations & Technical Assistance. Forecasted.  Estimated application due date TBD based on public health emergency needs.
NC Biotech Center Flash Grant Seeks small-scale proposals pertaining to COVID-19 vaccine development, diagnosis, and specific therapies. Cycle 1: 8/12/20

Cycle 2: 11/11/20

Cycle 3: 3/10/21

NIH/NIAID Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R01 Clinical Trial Not Allowed) Rolling
NIH/NIAID Emergency Awards: Rapid Investigation of SARS-CoV-2 and COVID-19 (R21, Clinical Trial Not Allowed) Rolling
NIH While research related to the direct clinical effects of COVID-19 are supported by other funding opportunities, the purpose of this funding opportunity is to focus on the role and impact of digital health interventions [e.g., mobile health (mhealth), telemedicine and telehealth, health information technology (IT), and wearable devices] to address access, reach, delivery, effectiveness, scalability and sustainability of health assessments and interventions for secondary effects, particularly in populations who experience health disparities and vulnerable populations. 3/02/2021
NIH Research that can be translated into interventions in order to reduce infection and transmission of HIV in patients with alcohol use disorders. 11/17/2020
NIH This FOA invites applications that propose a Center for Diabetes Translation Research (CDTR) to advance research along the spectrum of diabetes T2-T4 translational research (i.e., bedside to clinical practice and community settings, dissemination and implementation).  LOIs are due by September 20, 2020; full proposals by October 20, 2020.
NIH This program supports early stage investigators proposing highly innovative studies that open new areas of research for the genetics or epigenetics of addiction.  LOIs are due by September 19, 2020; full proposals by October 19, 2020.
NIH Mechanistic Studies of the Interaction between SARS-CoV-2/COVID-19 and Diseases and Organ Systems of Interest to NIDDK (R01 Clinical Trial Optional) Supports COVID-19 research pertaining to susceptibility, routes of infection, course of disease, morbidity and mortality in people with pre-existing diseases, or adverse acute or chronic outcomes in organs, tissues, and biological systems of specific interest to NIDDK. (Deadline is for LOI.) 11/16/20
NIH Community Interventions to Address the Consequences of the COVID-19 Pandemic among Health Disparity and Vulnerable Populations (R01 Clinical Trial Optional) August 28, 2020;

December 1, 2020

NIH Cyber-Physical Systems: Encourages CPS research and technology development to facilitate medical treatment and health-related initiatives for COVID-19. 12/2/20
NIH NIA Multi-site COVID-19 Related Clinical Trial Implementation Grant on Aging-Related Topics in at-risk Older Adult Populations (R01 Clinical Trial Required) 2/1/21
NIH Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19 (R01 Clinical Trial Optional) 3/2/21
NIH The goal of the National Institute of General Medical Sciences Ruth L. Kirschstein National Research Service Award Predoctoral Institutional Research Training Grant (T32) program is to develop a diverse pool of well-trained scientists available to address the Nation’s biomedical research agenda.  Proposals are due by standard tri-annual NIH dates.
NIH Notice of Special Interest (NOSI): Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 10/6/2020
NIH Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required) 1/14/2023
NIH NINDS Morris K. Udall Parkinson’s Disease Research Center Without Walls & Centers of Excellence (P20 / P50 Clinical Trial Optional) LOIs are due by August 28, 2020; full proposals by September 28, 2020.
NIH Assay Development and Screening for Discovery of Chemical Probes, Drugs or Immunomodulators (R01 Clinical Trial Not Allowed) (NIH) LOIs are due 30 days before standard tri-annual NIH due dates.
NIH BRAIN Initiative: Tools for Germline Gene Editing in Marmosets (U01 Clinical Trial Not Allowed) (NIH) LOIs are due by September 15, 2020; full proposals by October 15, 2020.
NIH NIDA Core Center of Excellence Grant Program (P30 Clinical Trial Optional) (NIH) LOIs are due by August 25, 2020; full proposals by September 25, 2020 (with similar due dates in 2021 and 2022).
NIH Integrative Research to Understand the Impact of Sex Differences on the Molecular Determinants of AD Risk and Responsiveness to Treatment (R01 Clinical Trial Optional) (NIH) LOIs are due by October 10, 2020; full proposals by November 10, 2020.
NIH Fertility Status as a Marker for Overall Health (R21 Clinical Trial Not Allowed) (NIH) LOIs are due by September 19, 2020; full proposals by October 19, 2020.
Private Funding Opportunities
CEPI Invites applicants to submit proposals for projects to develop vaccine candidates and support clinical trials involving vaccine candidates. Deadlines vary from Aug. 31 to Sept. 28, 2020, by track.
CETF Seeks research funding to find an existing drug or drug combination that, when given early, can reduce COVID-19 hospitalization and fatality rates by 75% or more Rolling
Cisco Supports research for detecting viral evolution, developing contact tracing, and other areas pertaining to COVID-19. Rolling
Ferring Ferring COVID-19 Investigational Grants in Reproductive Medicine and Maternal Health 10/21/20
Mozilla To provide awards of up to $50,000 each to open source technology projects which are responding to the COVID-19 pandemic in some way Applications accepted on a rolling basis
The Robert Wood Johnson Foundation Pioneering Ideas: Exploring the Future to Build a Culture of Health Rolling
Russell Sage Foundation COVID-19 Social Sciences Research: Funds research on social, political, economic, and psychological consequences of the pandemic through RSF’s core programs. 11/11/20
Social Science Research Council Just Tech Covid-19 Rapid-Response Grants: Seeks proposals from across the social sciences and related fields that address the risks, opportunities, and challenges posed by public health surveillance  Rolling
 
InfoEd SPIN has developed a specific search dedicated to COVID-19 opportunities:
SPIN Curated List of Funding Announcements for COVID-19 Research(link is external) 
Top
A notice to the TCNJ community: visit the OGSR COVID-19 information and updates pageRead More